249 related articles for article (PubMed ID: 31658440)
1. Somatic and germline mutations in the pathogenesis of pituitary adenomas.
Vandeva S; Daly AF; Petrossians P; Zacharieva S; Beckers A
Eur J Endocrinol; 2019 Dec; 181(6):R235-R254. PubMed ID: 31658440
[TBL] [Abstract][Full Text] [Related]
2. Screening for genetic causes of growth hormone hypersecretion.
Rostomyan L; Beckers A
Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
[TBL] [Abstract][Full Text] [Related]
5. Novel Genetic Causes of Pituitary Adenomas.
Caimari F; Korbonits M
Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
[TBL] [Abstract][Full Text] [Related]
6. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
7. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
[TBL] [Abstract][Full Text] [Related]
8. [Familial pituitary adenomas].
Burlacu MC; Tichomirowa M; Daly A; Beckers A
Presse Med; 2009 Jan; 38(1):112-6. PubMed ID: 18990538
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas.
Vasilev V; Daly AF; Zacharieva S; Beckers A
Horm Metab Res; 2020 Aug; 52(8):553-561. PubMed ID: 32299111
[TBL] [Abstract][Full Text] [Related]
10. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
Iacovazzo D; Caswell R; Bunce B; Jose S; Yuan B; Hernández-Ramírez LC; Kapur S; Caimari F; Evanson J; Ferraù F; Dang MN; Gabrovska P; Larkin SJ; Ansorge O; Rodd C; Vance ML; Ramírez-Renteria C; Mercado M; Goldstone AP; Buchfelder M; Burren CP; Gurlek A; Dutta P; Choong CS; Cheetham T; Trivellin G; Stratakis CA; Lopes MB; Grossman AB; Trouillas J; Lupski JR; Ellard S; Sampson JR; Roncaroli F; Korbonits M
Acta Neuropathol Commun; 2016 Jun; 4(1):56. PubMed ID: 27245663
[TBL] [Abstract][Full Text] [Related]
11. Genetic mutations in sporadic pituitary adenomas--what to screen for?
Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
[TBL] [Abstract][Full Text] [Related]
12. The genetics of pituitary adenomas.
Vandeva S; Jaffrain-Rea ML; Daly AF; Tichomirowa M; Zacharieva S; Beckers A
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):461-76. PubMed ID: 20833337
[TBL] [Abstract][Full Text] [Related]
13. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
Pepe S; Korbonits M; Iacovazzo D
J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 4.
Lee M; Pellegata NS
Front Horm Res; 2013; 41():63-78. PubMed ID: 23652671
[TBL] [Abstract][Full Text] [Related]
15. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
16. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.
Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K
J Clin Endocrinol Metab; 2022 Jul; 107(8):2339-2349. PubMed ID: 35323929
[TBL] [Abstract][Full Text] [Related]
17. MEN4 and
Alrezk R; Hannah-Shmouni F; Stratakis CA
Endocr Relat Cancer; 2017 Oct; 24(10):T195-T208. PubMed ID: 28824003
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
[TBL] [Abstract][Full Text] [Related]
19. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
[TBL] [Abstract][Full Text] [Related]
20. Familial pituitary tumor syndromes.
Elston MS; McDonald KL; Clifton-Bligh RJ; Robinson BG
Nat Rev Endocrinol; 2009 Aug; 5(8):453-61. PubMed ID: 19564887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]